Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Children's cancers, Leukaemia
Results
Phase 2
This trial looked at a drug called blinatumomab for children and teenagers with a type of acute lymphoblastic leukaemia (ALL) called B cell precursor ALL.
Recruitment start: 30 January 2012
Recruitment end: 3 June 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Ajay Vora
Amgen
NIHR Clinical Research Network: Cancer
Last reviewed: 16 Jul 2018
CRUK internal database number: 11767
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
